Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancer

23 Jan 2013

Abstract excerpt

OBJECTIVES: This study retrospectively evaluated the prognostic significance of downregulated protocadherin-10 (PCDH10) gene expression in bladder cancer. METHODS: To evaluate the prognostic significance of downregulated PCDH10 protein levels, immunohistochemistry was used to assess the level of PCDH10 protein in surgically-resected formalin-fixed, paraffin wax-embedded transitional cell carcinoma specimens....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Proteoglycans and glycosaminoglycans research
Share to Wnt/β-catenin signaling in development and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23569128
DOI: 10.1177/0300060513476989

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancerPMID 23569128Read ↗

Clinical and Prognostic Significance of Protocadherin-10 (PCDH10) Promoter Methylation in Bladder CancerSemantic proximity Read ↗

Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancerSemantic proximity Read ↗

Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patientsSemantic proximity Read ↗

p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder CancerSemantic proximity Read ↗

Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosisSemantic proximity Read ↗

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancerSemantic proximity Read ↗

Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.Semantic proximity Read ↗

Characterization of genes associated with different phenotypes of human bladder cancer cells.Semantic proximity Read ↗

PCDH10, a novel p53 transcriptional target in regulating cell migrationSemantic proximity Read ↗

bc10: A novel human bladder cancer‐associated protein with a conserved genomic structure downregulated in invasive cancerSemantic proximity Read ↗

Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder TumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.